The Platelet Services team will be attending ELRIG Drug Discovery 2022 on the 4-5 October 2022 in London.
The two-day event is Europe’s largest meeting for life sciences industry professionals and provides a platform for the drug discovery community to meet, network and collaborate.
Natalia Dovlatova (CEO), Wendy Tomlinson (CSO), Bob Humphries (Non-Executive Director, Drug Discovery Advisor) and Andrew Johnson (Laboratory Manager) will all be in attendance. Learn more about our team here.
The event will focus on a variety of topics including: Overcoming Challenges and New Directions in Medicinal Chemistry, High Content Imaging in Drug Discovery, Cell & Gene Therapy, Drug Discovery & Development in COPD, Innovation through partnership and Developments in Preclinical Models.
We will be presenting the poster titled ‘The role of platelet function and viability testing in addressing observations of suspected drug-induced thrombocytopenia’.
We look forward to catching up and collaborating with friends and clients. To arrange a meeting with a member of the team at ELRIG, please drop us an email: info@plateletservices.com and for more information on ELRIG Drug Discovery 2022, click here.
